Growth Metrics

Teladoc Health (TDOC) EPS (Weighted Average and Diluted) (2019 - 2026)

Teladoc Health's EPS (Weighted Average and Diluted) history spans 8 years, with the latest figure at -$0.36 for Q1 2026.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 32.08% to -$0.36 in Q1 2026 year-over-year; TTM through Mar 2026 was -$0.97, a 83.56% increase, with the full-year FY2025 number at -$1.14, up 80.58% from a year prior.
  • EPS (Weighted Average and Diluted) hit -$0.36 in Q1 2026 for Teladoc Health, down from -$0.14 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for TDOC hit a ceiling of -$0.14 in Q4 2025 and a floor of -$41.58 in Q1 2022.
  • Historically, EPS (Weighted Average and Diluted) has averaged -$5.5 across 5 years, with a median of -$0.4 in 2023.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): plummeted 46920.0% in 2022 and later soared 99.28% in 2023.
  • Tracing TDOC's EPS (Weighted Average and Diluted) over 5 years: stood at -$23.51 in 2022, then soared by 99.28% to -$0.17 in 2023, then crashed by 52.94% to -$0.26 in 2024, then skyrocketed by 46.15% to -$0.14 in 2025, then tumbled by 157.14% to -$0.36 in 2026.
  • Business Quant data shows EPS (Weighted Average and Diluted) for TDOC at -$0.36 in Q1 2026, -$0.14 in Q4 2025, and -$0.28 in Q3 2025.